nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—SLCO1B1—Irinotecan—pancreatic cancer	0.122	0.163	CbGbCtD
Gemfibrozil—CYP2C8—Tamoxifen—pancreatic cancer	0.0671	0.09	CbGbCtD
Gemfibrozil—CYP1A2—Dacarbazine—pancreatic cancer	0.0653	0.0875	CbGbCtD
Gemfibrozil—CYP2C8—Erlotinib—pancreatic cancer	0.0571	0.0765	CbGbCtD
Gemfibrozil—CYP2C19—Tamoxifen—pancreatic cancer	0.0563	0.0755	CbGbCtD
Gemfibrozil—CYP1A2—Tamoxifen—pancreatic cancer	0.052	0.0696	CbGbCtD
Gemfibrozil—CYP2C8—Fluorouracil—pancreatic cancer	0.0495	0.0663	CbGbCtD
Gemfibrozil—CYP2C9—Tamoxifen—pancreatic cancer	0.0468	0.0628	CbGbCtD
Gemfibrozil—CYP1A2—Erlotinib—pancreatic cancer	0.0442	0.0592	CbGbCtD
Gemfibrozil—CYP1A2—Fluorouracil—pancreatic cancer	0.0383	0.0513	CbGbCtD
Gemfibrozil—CYP2C9—Fluorouracil—pancreatic cancer	0.0345	0.0462	CbGbCtD
Gemfibrozil—CYP3A4—Tamoxifen—pancreatic cancer	0.0272	0.0365	CbGbCtD
Gemfibrozil—CYP3A4—Erlotinib—pancreatic cancer	0.0232	0.031	CbGbCtD
Gemfibrozil—CYP3A4—Irinotecan—pancreatic cancer	0.0209	0.028	CbGbCtD
Gemfibrozil—CYP3A4—Docetaxel—pancreatic cancer	0.0153	0.0205	CbGbCtD
Gemfibrozil—CYP3A4—Sunitinib—pancreatic cancer	0.0153	0.0204	CbGbCtD
Gemfibrozil—CYP3A4—Doxorubicin—pancreatic cancer	0.0114	0.0153	CbGbCtD
Gemfibrozil—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000397	0.00156	CcSEcCtD
Gemfibrozil—Skin disorder—Gemcitabine—pancreatic cancer	0.000394	0.00155	CcSEcCtD
Gemfibrozil—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000391	0.00154	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000391	0.00154	CcSEcCtD
Gemfibrozil—Dizziness—Tamoxifen—pancreatic cancer	0.00039	0.00154	CcSEcCtD
Gemfibrozil—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.000387	0.00153	CcSEcCtD
Gemfibrozil—Dizziness—Erlotinib—pancreatic cancer	0.000386	0.00152	CcSEcCtD
Gemfibrozil—Eye disorder—Docetaxel—pancreatic cancer	0.000379	0.00149	CcSEcCtD
Gemfibrozil—Vomiting—Tamoxifen—pancreatic cancer	0.000375	0.00148	CcSEcCtD
Gemfibrozil—Paraesthesia—Irinotecan—pancreatic cancer	0.000374	0.00147	CcSEcCtD
Gemfibrozil—Rash—Tamoxifen—pancreatic cancer	0.000372	0.00147	CcSEcCtD
Gemfibrozil—Dermatitis—Tamoxifen—pancreatic cancer	0.000372	0.00146	CcSEcCtD
Gemfibrozil—Vomiting—Erlotinib—pancreatic cancer	0.000371	0.00146	CcSEcCtD
Gemfibrozil—Somnolence—Irinotecan—pancreatic cancer	0.00037	0.00146	CcSEcCtD
Gemfibrozil—Headache—Tamoxifen—pancreatic cancer	0.00037	0.00146	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00037	0.00146	CcSEcCtD
Gemfibrozil—Rash—Erlotinib—pancreatic cancer	0.000368	0.00145	CcSEcCtD
Gemfibrozil—Dermatitis—Erlotinib—pancreatic cancer	0.000368	0.00145	CcSEcCtD
Gemfibrozil—Dyspepsia—Irinotecan—pancreatic cancer	0.000367	0.00144	CcSEcCtD
Gemfibrozil—Headache—Erlotinib—pancreatic cancer	0.000366	0.00144	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000365	0.00144	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Epirubicin—pancreatic cancer	0.000365	0.00144	CcSEcCtD
Gemfibrozil—Paraesthesia—Gemcitabine—pancreatic cancer	0.000364	0.00143	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000363	0.00143	CcSEcCtD
Gemfibrozil—Asthenia—Sunitinib—pancreatic cancer	0.000363	0.00143	CcSEcCtD
Gemfibrozil—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000361	0.00142	CcSEcCtD
Gemfibrozil—Somnolence—Gemcitabine—pancreatic cancer	0.000361	0.00142	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00036	0.00142	CcSEcCtD
Gemfibrozil—Fatigue—Irinotecan—pancreatic cancer	0.000359	0.00141	CcSEcCtD
Gemfibrozil—Paraesthesia—Fluorouracil—pancreatic cancer	0.000358	0.00141	CcSEcCtD
Gemfibrozil—Alopecia—Docetaxel—pancreatic cancer	0.000358	0.00141	CcSEcCtD
Gemfibrozil—Pruritus—Sunitinib—pancreatic cancer	0.000358	0.00141	CcSEcCtD
Gemfibrozil—Breast disorder—Epirubicin—pancreatic cancer	0.000357	0.00141	CcSEcCtD
Gemfibrozil—Pain—Irinotecan—pancreatic cancer	0.000356	0.0014	CcSEcCtD
Gemfibrozil—Constipation—Irinotecan—pancreatic cancer	0.000356	0.0014	CcSEcCtD
Gemfibrozil—Mental disorder—Docetaxel—pancreatic cancer	0.000355	0.0014	CcSEcCtD
Gemfibrozil—Somnolence—Fluorouracil—pancreatic cancer	0.000355	0.0014	CcSEcCtD
Gemfibrozil—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000353	0.00139	CcSEcCtD
Gemfibrozil—Dyspepsia—Fluorouracil—pancreatic cancer	0.000351	0.00138	CcSEcCtD
Gemfibrozil—Nausea—Tamoxifen—pancreatic cancer	0.000351	0.00138	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00035	0.00138	CcSEcCtD
Gemfibrozil—Fatigue—Gemcitabine—pancreatic cancer	0.00035	0.00138	CcSEcCtD
Gemfibrozil—Muscular weakness—Epirubicin—pancreatic cancer	0.000348	0.00137	CcSEcCtD
Gemfibrozil—Pain—Gemcitabine—pancreatic cancer	0.000347	0.00137	CcSEcCtD
Gemfibrozil—Constipation—Gemcitabine—pancreatic cancer	0.000347	0.00137	CcSEcCtD
Gemfibrozil—Nausea—Erlotinib—pancreatic cancer	0.000347	0.00137	CcSEcCtD
Gemfibrozil—Diarrhoea—Sunitinib—pancreatic cancer	0.000346	0.00136	CcSEcCtD
Gemfibrozil—Dysgeusia—Docetaxel—pancreatic cancer	0.000345	0.00136	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000344	0.00136	CcSEcCtD
Gemfibrozil—Feeling abnormal—Irinotecan—pancreatic cancer	0.000343	0.00135	CcSEcCtD
Gemfibrozil—Pain—Fluorouracil—pancreatic cancer	0.000341	0.00134	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000341	0.00134	CcSEcCtD
Gemfibrozil—Eosinophilia—Epirubicin—pancreatic cancer	0.000338	0.00133	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000337	0.00133	CcSEcCtD
Gemfibrozil—Pancreatitis—Epirubicin—pancreatic cancer	0.000335	0.00132	CcSEcCtD
Gemfibrozil—Dizziness—Sunitinib—pancreatic cancer	0.000334	0.00132	CcSEcCtD
Gemfibrozil—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000334	0.00132	CcSEcCtD
Gemfibrozil—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000334	0.00132	CcSEcCtD
Gemfibrozil—Breast disorder—Doxorubicin—pancreatic cancer	0.00033	0.0013	CcSEcCtD
Gemfibrozil—Abdominal pain—Irinotecan—pancreatic cancer	0.000329	0.0013	CcSEcCtD
Gemfibrozil—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000329	0.00129	CcSEcCtD
Gemfibrozil—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000327	0.00129	CcSEcCtD
Gemfibrozil—Anaemia—Docetaxel—pancreatic cancer	0.000326	0.00128	CcSEcCtD
Gemfibrozil—Pancytopenia—Epirubicin—pancreatic cancer	0.000324	0.00128	CcSEcCtD
Gemfibrozil—Muscular weakness—Doxorubicin—pancreatic cancer	0.000322	0.00127	CcSEcCtD
Gemfibrozil—Vomiting—Sunitinib—pancreatic cancer	0.000321	0.00127	CcSEcCtD
Gemfibrozil—Rash—Sunitinib—pancreatic cancer	0.000319	0.00126	CcSEcCtD
Gemfibrozil—Dermatitis—Sunitinib—pancreatic cancer	0.000318	0.00125	CcSEcCtD
Gemfibrozil—Urticaria—Fluorouracil—pancreatic cancer	0.000317	0.00125	CcSEcCtD
Gemfibrozil—Headache—Sunitinib—pancreatic cancer	0.000317	0.00125	CcSEcCtD
Gemfibrozil—Syncope—Docetaxel—pancreatic cancer	0.000316	0.00125	CcSEcCtD
Gemfibrozil—Leukopenia—Docetaxel—pancreatic cancer	0.000316	0.00124	CcSEcCtD
Gemfibrozil—Eosinophilia—Doxorubicin—pancreatic cancer	0.000313	0.00123	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000312	0.00123	CcSEcCtD
Gemfibrozil—Loss of consciousness—Docetaxel—pancreatic cancer	0.00031	0.00122	CcSEcCtD
Gemfibrozil—Pancreatitis—Doxorubicin—pancreatic cancer	0.00031	0.00122	CcSEcCtD
Gemfibrozil—Weight decreased—Epirubicin—pancreatic cancer	0.000309	0.00122	CcSEcCtD
Gemfibrozil—Cough—Docetaxel—pancreatic cancer	0.000308	0.00121	CcSEcCtD
Gemfibrozil—Convulsion—Docetaxel—pancreatic cancer	0.000306	0.0012	CcSEcCtD
Gemfibrozil—Myalgia—Docetaxel—pancreatic cancer	0.0003	0.00118	CcSEcCtD
Gemfibrozil—Arthralgia—Docetaxel—pancreatic cancer	0.0003	0.00118	CcSEcCtD
Gemfibrozil—Chest pain—Docetaxel—pancreatic cancer	0.0003	0.00118	CcSEcCtD
Gemfibrozil—Nausea—Sunitinib—pancreatic cancer	0.0003	0.00118	CcSEcCtD
Gemfibrozil—Pancytopenia—Doxorubicin—pancreatic cancer	0.0003	0.00118	CcSEcCtD
Gemfibrozil—Renal failure—Epirubicin—pancreatic cancer	0.000299	0.00118	CcSEcCtD
Gemfibrozil—Asthenia—Irinotecan—pancreatic cancer	0.000299	0.00118	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000298	0.00118	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000298	0.00117	CcSEcCtD
Gemfibrozil—Jaundice—Epirubicin—pancreatic cancer	0.000297	0.00117	CcSEcCtD
Gemfibrozil—Urinary tract infection—Epirubicin—pancreatic cancer	0.000296	0.00117	CcSEcCtD
Gemfibrozil—Asthenia—Gemcitabine—pancreatic cancer	0.000291	0.00115	CcSEcCtD
Gemfibrozil—Confusional state—Docetaxel—pancreatic cancer	0.00029	0.00114	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000288	0.00114	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000288	0.00113	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000288	0.00113	CcSEcCtD
Gemfibrozil—Oedema—Docetaxel—pancreatic cancer	0.000288	0.00113	CcSEcCtD
Gemfibrozil—Pruritus—Gemcitabine—pancreatic cancer	0.000287	0.00113	CcSEcCtD
Gemfibrozil—Weight decreased—Doxorubicin—pancreatic cancer	0.000286	0.00113	CcSEcCtD
Gemfibrozil—Diarrhoea—Irinotecan—pancreatic cancer	0.000285	0.00112	CcSEcCtD
Gemfibrozil—Shock—Docetaxel—pancreatic cancer	0.000283	0.00112	CcSEcCtD
Gemfibrozil—Nervous system disorder—Docetaxel—pancreatic cancer	0.000282	0.00111	CcSEcCtD
Gemfibrozil—Pruritus—Fluorouracil—pancreatic cancer	0.000282	0.00111	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000282	0.00111	CcSEcCtD
Gemfibrozil—Skin disorder—Docetaxel—pancreatic cancer	0.00028	0.0011	CcSEcCtD
Gemfibrozil—Diarrhoea—Gemcitabine—pancreatic cancer	0.000278	0.00109	CcSEcCtD
Gemfibrozil—Renal failure—Doxorubicin—pancreatic cancer	0.000277	0.00109	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000276	0.00109	CcSEcCtD
Gemfibrozil—Dizziness—Irinotecan—pancreatic cancer	0.000275	0.00108	CcSEcCtD
Gemfibrozil—Jaundice—Doxorubicin—pancreatic cancer	0.000275	0.00108	CcSEcCtD
Gemfibrozil—Rhinitis—Epirubicin—pancreatic cancer	0.000274	0.00108	CcSEcCtD
Gemfibrozil—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000274	0.00108	CcSEcCtD
Gemfibrozil—Diarrhoea—Fluorouracil—pancreatic cancer	0.000273	0.00108	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000272	0.00107	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000269	0.00106	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000266	0.00105	CcSEcCtD
Gemfibrozil—Vomiting—Irinotecan—pancreatic cancer	0.000265	0.00104	CcSEcCtD
Gemfibrozil—Dizziness—Fluorouracil—pancreatic cancer	0.000264	0.00104	CcSEcCtD
Gemfibrozil—Rash—Irinotecan—pancreatic cancer	0.000263	0.00103	CcSEcCtD
Gemfibrozil—Dermatitis—Irinotecan—pancreatic cancer	0.000262	0.00103	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000262	0.00103	CcSEcCtD
Gemfibrozil—Headache—Irinotecan—pancreatic cancer	0.000261	0.00103	CcSEcCtD
Gemfibrozil—Paraesthesia—Docetaxel—pancreatic cancer	0.000259	0.00102	CcSEcCtD
Gemfibrozil—Vomiting—Gemcitabine—pancreatic cancer	0.000258	0.00102	CcSEcCtD
Gemfibrozil—Somnolence—Docetaxel—pancreatic cancer	0.000256	0.00101	CcSEcCtD
Gemfibrozil—Rash—Gemcitabine—pancreatic cancer	0.000256	0.00101	CcSEcCtD
Gemfibrozil—Dermatitis—Gemcitabine—pancreatic cancer	0.000256	0.00101	CcSEcCtD
Gemfibrozil—Eye disorder—Epirubicin—pancreatic cancer	0.000255	0.00101	CcSEcCtD
Gemfibrozil—Headache—Gemcitabine—pancreatic cancer	0.000254	0.001	CcSEcCtD
Gemfibrozil—Vomiting—Fluorouracil—pancreatic cancer	0.000254	0.000999	CcSEcCtD
Gemfibrozil—Rhinitis—Doxorubicin—pancreatic cancer	0.000254	0.000999	CcSEcCtD
Gemfibrozil—Dyspepsia—Docetaxel—pancreatic cancer	0.000253	0.000998	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000252	0.000991	CcSEcCtD
Gemfibrozil—Rash—Fluorouracil—pancreatic cancer	0.000251	0.000991	CcSEcCtD
Gemfibrozil—Dermatitis—Fluorouracil—pancreatic cancer	0.000251	0.00099	CcSEcCtD
Gemfibrozil—Headache—Fluorouracil—pancreatic cancer	0.00025	0.000984	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000249	0.000979	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000249	0.000979	CcSEcCtD
Gemfibrozil—Fatigue—Docetaxel—pancreatic cancer	0.000248	0.000978	CcSEcCtD
Gemfibrozil—Nausea—Irinotecan—pancreatic cancer	0.000247	0.000974	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000246	0.00097	CcSEcCtD
Gemfibrozil—Pain—Docetaxel—pancreatic cancer	0.000246	0.00097	CcSEcCtD
Gemfibrozil—Constipation—Docetaxel—pancreatic cancer	0.000246	0.00097	CcSEcCtD
Gemfibrozil—Alopecia—Epirubicin—pancreatic cancer	0.000242	0.000951	CcSEcCtD
Gemfibrozil—Nausea—Gemcitabine—pancreatic cancer	0.000241	0.000949	CcSEcCtD
Gemfibrozil—Mental disorder—Epirubicin—pancreatic cancer	0.000239	0.000943	CcSEcCtD
Gemfibrozil—Feeling abnormal—Docetaxel—pancreatic cancer	0.000237	0.000935	CcSEcCtD
Gemfibrozil—Nausea—Fluorouracil—pancreatic cancer	0.000237	0.000933	CcSEcCtD
Gemfibrozil—Eye disorder—Doxorubicin—pancreatic cancer	0.000236	0.000931	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000235	0.000927	CcSEcCtD
Gemfibrozil—Flatulence—Epirubicin—pancreatic cancer	0.000234	0.000924	CcSEcCtD
Gemfibrozil—Tension—Epirubicin—pancreatic cancer	0.000233	0.00092	CcSEcCtD
Gemfibrozil—Dysgeusia—Epirubicin—pancreatic cancer	0.000233	0.000918	CcSEcCtD
Gemfibrozil—Nervousness—Epirubicin—pancreatic cancer	0.000231	0.00091	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000228	0.000898	CcSEcCtD
Gemfibrozil—Abdominal pain—Docetaxel—pancreatic cancer	0.000228	0.000896	CcSEcCtD
Gemfibrozil—Vision blurred—Epirubicin—pancreatic cancer	0.000224	0.000883	CcSEcCtD
Gemfibrozil—Alopecia—Doxorubicin—pancreatic cancer	0.000223	0.00088	CcSEcCtD
Gemfibrozil—Mental disorder—Doxorubicin—pancreatic cancer	0.000222	0.000873	CcSEcCtD
Gemfibrozil—Anaemia—Epirubicin—pancreatic cancer	0.00022	0.000866	CcSEcCtD
Gemfibrozil—Flatulence—Doxorubicin—pancreatic cancer	0.000217	0.000855	CcSEcCtD
Gemfibrozil—Tension—Doxorubicin—pancreatic cancer	0.000216	0.000851	CcSEcCtD
Gemfibrozil—Dysgeusia—Doxorubicin—pancreatic cancer	0.000216	0.000849	CcSEcCtD
Gemfibrozil—Nervousness—Doxorubicin—pancreatic cancer	0.000214	0.000842	CcSEcCtD
Gemfibrozil—Vertigo—Epirubicin—pancreatic cancer	0.000214	0.000842	CcSEcCtD
Gemfibrozil—Syncope—Epirubicin—pancreatic cancer	0.000213	0.00084	CcSEcCtD
Gemfibrozil—Leukopenia—Epirubicin—pancreatic cancer	0.000213	0.000839	CcSEcCtD
Gemfibrozil—Loss of consciousness—Epirubicin—pancreatic cancer	0.000209	0.000824	CcSEcCtD
Gemfibrozil—Cough—Epirubicin—pancreatic cancer	0.000208	0.000818	CcSEcCtD
Gemfibrozil—Vision blurred—Doxorubicin—pancreatic cancer	0.000207	0.000817	CcSEcCtD
Gemfibrozil—Asthenia—Docetaxel—pancreatic cancer	0.000207	0.000814	CcSEcCtD
Gemfibrozil—Convulsion—Epirubicin—pancreatic cancer	0.000206	0.000812	CcSEcCtD
Gemfibrozil—Pruritus—Docetaxel—pancreatic cancer	0.000204	0.000802	CcSEcCtD
Gemfibrozil—Anaemia—Doxorubicin—pancreatic cancer	0.000203	0.000802	CcSEcCtD
Gemfibrozil—Chest pain—Epirubicin—pancreatic cancer	0.000203	0.000798	CcSEcCtD
Gemfibrozil—Myalgia—Epirubicin—pancreatic cancer	0.000203	0.000798	CcSEcCtD
Gemfibrozil—Arthralgia—Epirubicin—pancreatic cancer	0.000203	0.000798	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000201	0.000792	CcSEcCtD
Gemfibrozil—Vertigo—Doxorubicin—pancreatic cancer	0.000198	0.000779	CcSEcCtD
Gemfibrozil—Syncope—Doxorubicin—pancreatic cancer	0.000197	0.000778	CcSEcCtD
Gemfibrozil—Leukopenia—Doxorubicin—pancreatic cancer	0.000197	0.000776	CcSEcCtD
Gemfibrozil—Diarrhoea—Docetaxel—pancreatic cancer	0.000197	0.000776	CcSEcCtD
Gemfibrozil—Confusional state—Epirubicin—pancreatic cancer	0.000196	0.000771	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000194	0.000765	CcSEcCtD
Gemfibrozil—Oedema—Epirubicin—pancreatic cancer	0.000194	0.000765	CcSEcCtD
Gemfibrozil—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000193	0.000762	CcSEcCtD
Gemfibrozil—Cough—Doxorubicin—pancreatic cancer	0.000192	0.000757	CcSEcCtD
Gemfibrozil—Shock—Epirubicin—pancreatic cancer	0.000191	0.000753	CcSEcCtD
Gemfibrozil—Convulsion—Doxorubicin—pancreatic cancer	0.000191	0.000751	CcSEcCtD
Gemfibrozil—Nervous system disorder—Epirubicin—pancreatic cancer	0.00019	0.00075	CcSEcCtD
Gemfibrozil—Dizziness—Docetaxel—pancreatic cancer	0.00019	0.00075	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00019	0.000749	CcSEcCtD
Gemfibrozil—Skin disorder—Epirubicin—pancreatic cancer	0.000189	0.000743	CcSEcCtD
Gemfibrozil—Chest pain—Doxorubicin—pancreatic cancer	0.000187	0.000738	CcSEcCtD
Gemfibrozil—Arthralgia—Doxorubicin—pancreatic cancer	0.000187	0.000738	CcSEcCtD
Gemfibrozil—Myalgia—Doxorubicin—pancreatic cancer	0.000187	0.000738	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000186	0.000733	CcSEcCtD
Gemfibrozil—Vomiting—Docetaxel—pancreatic cancer	0.000183	0.000721	CcSEcCtD
Gemfibrozil—Rash—Docetaxel—pancreatic cancer	0.000182	0.000715	CcSEcCtD
Gemfibrozil—Dermatitis—Docetaxel—pancreatic cancer	0.000181	0.000714	CcSEcCtD
Gemfibrozil—Confusional state—Doxorubicin—pancreatic cancer	0.000181	0.000714	CcSEcCtD
Gemfibrozil—Headache—Docetaxel—pancreatic cancer	0.00018	0.00071	CcSEcCtD
Gemfibrozil—Oedema—Doxorubicin—pancreatic cancer	0.00018	0.000708	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.00018	0.000708	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000177	0.000697	CcSEcCtD
Gemfibrozil—Shock—Doxorubicin—pancreatic cancer	0.000177	0.000696	CcSEcCtD
Gemfibrozil—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000176	0.000694	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000176	0.000693	CcSEcCtD
Gemfibrozil—Skin disorder—Doxorubicin—pancreatic cancer	0.000175	0.000687	CcSEcCtD
Gemfibrozil—Paraesthesia—Epirubicin—pancreatic cancer	0.000174	0.000687	CcSEcCtD
Gemfibrozil—Somnolence—Epirubicin—pancreatic cancer	0.000173	0.00068	CcSEcCtD
Gemfibrozil—Nausea—Docetaxel—pancreatic cancer	0.000171	0.000674	CcSEcCtD
Gemfibrozil—Dyspepsia—Epirubicin—pancreatic cancer	0.000171	0.000673	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000168	0.00066	CcSEcCtD
Gemfibrozil—Fatigue—Epirubicin—pancreatic cancer	0.000167	0.000659	CcSEcCtD
Gemfibrozil—Pain—Epirubicin—pancreatic cancer	0.000166	0.000654	CcSEcCtD
Gemfibrozil—Constipation—Epirubicin—pancreatic cancer	0.000166	0.000654	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000164	0.000645	CcSEcCtD
Gemfibrozil—Paraesthesia—Doxorubicin—pancreatic cancer	0.000161	0.000636	CcSEcCtD
Gemfibrozil—Feeling abnormal—Epirubicin—pancreatic cancer	0.00016	0.00063	CcSEcCtD
Gemfibrozil—Somnolence—Doxorubicin—pancreatic cancer	0.00016	0.000629	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000159	0.000625	CcSEcCtD
Gemfibrozil—Dyspepsia—Doxorubicin—pancreatic cancer	0.000158	0.000623	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000155	0.000611	CcSEcCtD
Gemfibrozil—Fatigue—Doxorubicin—pancreatic cancer	0.000155	0.00061	CcSEcCtD
Gemfibrozil—Urticaria—Epirubicin—pancreatic cancer	0.000154	0.000608	CcSEcCtD
Gemfibrozil—Constipation—Doxorubicin—pancreatic cancer	0.000154	0.000605	CcSEcCtD
Gemfibrozil—Pain—Doxorubicin—pancreatic cancer	0.000154	0.000605	CcSEcCtD
Gemfibrozil—Abdominal pain—Epirubicin—pancreatic cancer	0.000154	0.000605	CcSEcCtD
Gemfibrozil—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000148	0.000583	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000147	0.000579	CcSEcCtD
Gemfibrozil—Urticaria—Doxorubicin—pancreatic cancer	0.000143	0.000562	CcSEcCtD
Gemfibrozil—Abdominal pain—Doxorubicin—pancreatic cancer	0.000142	0.000559	CcSEcCtD
Gemfibrozil—Asthenia—Epirubicin—pancreatic cancer	0.000139	0.000549	CcSEcCtD
Gemfibrozil—Pruritus—Epirubicin—pancreatic cancer	0.000137	0.000541	CcSEcCtD
Gemfibrozil—Diarrhoea—Epirubicin—pancreatic cancer	0.000133	0.000523	CcSEcCtD
Gemfibrozil—Asthenia—Doxorubicin—pancreatic cancer	0.000129	0.000508	CcSEcCtD
Gemfibrozil—Dizziness—Epirubicin—pancreatic cancer	0.000128	0.000506	CcSEcCtD
Gemfibrozil—Pruritus—Doxorubicin—pancreatic cancer	0.000127	0.000501	CcSEcCtD
Gemfibrozil—Vomiting—Epirubicin—pancreatic cancer	0.000123	0.000486	CcSEcCtD
Gemfibrozil—Diarrhoea—Doxorubicin—pancreatic cancer	0.000123	0.000484	CcSEcCtD
Gemfibrozil—Rash—Epirubicin—pancreatic cancer	0.000122	0.000482	CcSEcCtD
Gemfibrozil—Dermatitis—Epirubicin—pancreatic cancer	0.000122	0.000482	CcSEcCtD
Gemfibrozil—Headache—Epirubicin—pancreatic cancer	0.000122	0.000479	CcSEcCtD
Gemfibrozil—Dizziness—Doxorubicin—pancreatic cancer	0.000119	0.000468	CcSEcCtD
Gemfibrozil—Nausea—Epirubicin—pancreatic cancer	0.000115	0.000454	CcSEcCtD
Gemfibrozil—Vomiting—Doxorubicin—pancreatic cancer	0.000114	0.00045	CcSEcCtD
Gemfibrozil—Rash—Doxorubicin—pancreatic cancer	0.000113	0.000446	CcSEcCtD
Gemfibrozil—Dermatitis—Doxorubicin—pancreatic cancer	0.000113	0.000446	CcSEcCtD
Gemfibrozil—Headache—Doxorubicin—pancreatic cancer	0.000113	0.000443	CcSEcCtD
Gemfibrozil—Nausea—Doxorubicin—pancreatic cancer	0.000107	0.00042	CcSEcCtD
